Related Experiment Video
Updated: Jan 25, 2026

Author Spotlight: Advancing 3D Coculture Systems with PVA-PCL Nanofibrous Membranes
Published on: December 27, 2024
Short fluorocarbon chains containing hydrophobic nanofibrous membranes with improved hemocompatibility,
Ying Wang1, Yuqing Liu2, Menglong Liu1
1Institute of Burn Research, Southwest Hospital, State Key Laboratory of Trauma, Burn and Combined Injury, Third Military Medical University (Army Medical University), Chongqing, 400038, China; Chongqing Key Laboratory for Disease Proteomics, Chongqing, 400038, China.
Abstract:
Thromboembolic diseases have become one of the most hazardous and mortal diseases to human life. In this paper, a highly hydrophobic nanofibrous membrane was prepared via electrospinning of PCL-b-PHFBA (polycaprolactone -b- poly (heptafluoro butyl acrylate)) block copolymers. The nanofibrous membranes showed high hydrophobicity with a water contact angle of ˜136° due to their rough nanofibrous surface morphology and contained small portion of short fluorocarbon chain polymer PHFBA. According to the results of whole blood clotting time (CT), prothrombin time (PT), activated partial thromboplastin time (APTT), plasma re-calcification time test (PRT), platelets adhesion and the ultra-low hemolysis rate of 1.13% to red blood cells (RBCs), the membranes exhibited interesting anticoagulant and decreased-platelet adhesion performance. PCL-b-PHFBA nanofibrous membranes showed mild anti-fouling activity, reduced Bovine Serum albumin (BSA) protein absorption and bacterial adhesion compared with PCL nanofibrous membranes. The introduction of PHFBA component did not lead to any obvious cytotoxicity according to the cytocompatibility and cell adhesion study, suggesting that the PCL-b-PHFBA nanofibrous membranes are promising for blood related applications by minimizing the coagulation, hemolysis, BSA protein adsorption, bacterial attachment and platelet adhesion.
More Related Videos
07:08Assessment of the Anticoagulant and Anti-inflammatory Properties of Endothelial Cells Using 3D Cell Culture and Non-anticoagulated Whole Blood
Published on: September 5, 2017
06:45Author Spotlight: Optimizing Hollow-Fiber Membranes for Continuous Liquid-Liquid Extraction of Medium-Chain Fatty Acids
Published on: August 9, 2024
Related Concept Videos
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Introduction to Membrane Proteins
Electron Transport Chains
The ETC is comprised of...
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Improving Translational Accuracy
Short-distance Transport of Resources